Article
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
2018-08-29
Abstract excerpt
<h4>ABSTRACT</h4> Trisomy 21 (T21) causes Down syndrome (DS), affecting immune and neurological function by unknown mechanisms. We report here the results of a large metabolomics study showing that people with DS produce elevated levels of kynurenine and quinolinic acid, two tryptophan catabolites with potent immunosuppressive and neurotoxic properties, respectively. We found that immune cells of people with DS o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e280a38e-86f8-5ded-ba38-ac179110b604
- DOI
- 10.1101/403642
